Xia, Youli
Fan, Cheng
Hoadley, Katherine A. http://orcid.org/0000-0002-1216-477X
Parker, Joel S. http://orcid.org/0000-0003-2080-6901
Perou, Charles M. http://orcid.org/0000-0001-9827-2247
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P50-CA58223, RO1-CA148761, RO1-CA195740)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Breast Cancer Research Foundation
Susan G. Komen (SAC-160074, CCR16376756)
V Foundation for Cancer Research
Article History
Received: 30 April 2019
Accepted: 11 November 2019
First Online: 11 December 2019
Competing interests
: C.M.P is an equity stock holder and consultant of BioClassifier LLC. C.M.P and J.S.P are listed as an inventor on patent applications on the Breast PAM50 assay. The other authors declare no competing interests.